Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial

Publication date: Available online 5 March 2020Source: The Lancet HaematologyAuthor(s): Eytan M Stein, Amir T Fathi, Courtney D DiNardo, Daniel A Pollyea, Gail J Roboz, Robert Collins, Mikkael A Sekeres, Richard M Stone, Eyal C Attar, Mark G Frattini, Alessandra Tosolini, Qiang Xu, Wendy L See, Kyle J MacBeth, Stéphane de Botton, Martin S Tallman, Hagop M Kantarjian
Source: The Lancet Haematology - Category: Hematology Source Type: research